Medlab Clinical Ltd. (MDLB)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	18.16M
Revenue (ttm)	1.54M +109.7%
Net Income	-7.16M
EPS	-1.75
Shares Out	4.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About MDLB

Medlab Clinical is an Australian biotechnology company that formulates innovative solutions and innovative consumer health care products to provide integrative patient care. Our aim is to disrupt the multi-billion-dollar market of delivery platform technologies for pharmaceutical products that are designed to treat pain and mental health. We were incorporated in Australia in April 2014, and in 2015 listed on the ASX under the symbol “MDC.” Our corporate headquarters are located in Australia, and we maintain offices in the United States and Euro...

• Industry: Health Care
• Sector: Biotechnology
• Founded: 2014
• Employees: 42
• Stock Exchange: NASDAQ
• Ticker Symbol: MDLB
• Website: https://www.medlab.co/

Financial Performance

Data Source: SEC filings Last updated: Aug 14, 2026

The data for this page was gathered manually by the Stock Analysis team, from official company filings available on SEC.gov.

Data Sources Report a data error